Fundz

480 Biomedical, Inc. reported raising $6 Million in an initial SEC Form D filing, from an offering of $6 Million

TAKEN PRIVATENov 28, 2016

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Nov 28, 2016)

Round Type

Venture

WatertownOtherBiotechnology

Quick answer

Lyra Therapeutics, Inc. raised $6 Million in a funding round, dated November 28, 2016. Lyra Therapeutics, Inc. is based in Watertown, Massachusetts, United States.

How much did Lyra Therapeutics, Inc. raise?
Lyra Therapeutics, Inc. raised $6 Million in a funding round on November 28, 2016.
What does Lyra Therapeutics, Inc. do?
Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to..
Where is Lyra Therapeutics, Inc. based and how big is it?
Lyra Therapeutics, Inc. is based in Watertown, Massachusetts, United States.
Who are the decision-makers at Lyra Therapeutics, Inc?
Fundz holds 1 contact at Lyra Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Lyra Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Avenzo Therapeutics raised $386M (Pre-Seed) on January 12, 2017.
  • Cavion, Inc. raised $22M on January 12, 2017.
  • IRX Therapeutics, Inc. raised $13M on January 12, 2017.
  • OXOS Medical raised $50K (Pre-Seed) on January 12, 2017.
  • APOLLO ENDOSURGERY US INC raised $54M on January 11, 2017.
  • Dynatronics raised $975K (Seed) on January 11, 2017.

Who to call at Lyra Therapeutics, Inc., and when

A new round usually means Lyra Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lyra Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lyra Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lyra Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lyra Therapeutics, Inc.

Location

480 Arsenal Way

Watertown, Massachusetts, United States

About

Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. Building on expertise in materials science, drug development and formulation, Lyra has developed proprietary technology that is designed to deliver medicines directly precisely and consistently to the affected tissue for sustained periods with a single administration. Our product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, in-office procedure and intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages for the treatment of CRS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lyra Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMaria P., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lyra Therapeutics, Inc.'s next move

See what Strategic adds

Lyra Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.